Pulmicort inhaler discontinued

Asthma patients using Pulmicort CFC-free inhaler need to transfer to a suitable alternative
Asthma patients using Pulmicort CFC-free inhaler need to transfer to a suitable alternative

AstraZeneca has discontinued production of the Pulmicort (budesonide) CFC-free pressurised metered-dose inhaler and the NebuChamber spacer owing to manufacturing difficulties relating to technical aspects of the inhaler.

Patients can continue using Pulmicort inhaler until their supply is finished. They will then need to be transferred to an appropriate alternative such as Pulmicort Turbohaler, Easyhaler Budesonide or Budelin Novolizer.

Healthcare professionals should note that these products may require different inhalation techniques to Pulmicort. Patients may need to be advised and assessed on correct usage. Some preparations contain lactose and therefore should not be used in patients who are lactose intolerant.

Further information: AstraZeneca

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Drug shortages - live tracker

Drug shortages - live tracker

Check on the latest drug supply issues with MIMS' shortages...

Novel MS drug gains NICE approval

Novel MS drug gains NICE approval

New NICE guidance recommends ocrelizumab (Ocrevus)...

Emollients, Potential Skin Sensitisers as Ingredients

Emollients, Potential Skin Sensitisers as Ingredients

Potential sensitising agents in emollient preparations.

NICE recommends new triple therapy option for diabetes

NICE recommends new triple therapy option for diabetes

Ertugliflozin (Steglatro) can now be prescribed routinely...